Alveus raises $197 million in Series A to develop next-generation therapies for obesity and metabolic diseases.

vist.ly/4uuf3

#longevity #Obesity #MetabolicHealth #BiotechFunding #DrugDevelopment #HealthInnovation #Biopharma

Strategic licensing partnership brings fresh capital while narrowing the company’s focus on therapies targeting the biology of aging.

vist.ly/4uqhc

#longevity #BiotechFunding #CellTherapy #AgingBiology #BiotechIndustry #RegenerativeMedicine

ARPA-H backs a first-of-its-kind effort to test whether medicine can protect health before decline begins.

vist.ly/4s28s

#longevity #biotechfunding #ARPAH #healthspan #geroscience #preventivemedicine #agingresearch #venturecapital

Fresh backing from Michael J Fox Foundation and Wellcome expands Lario’s calcium channel platform into Parkinson’s disease and PTSD.

vist.ly/4s7qh

#longevity #Neuroscience #BrainHealth #CNSDrugs #DrugDevelopment #BiotechFunding #Neurodegeneration #TranslationalMedicine

AI-powered drug discovery startup Peptris raised ₹70 Cr in Series A funding, co-led by IAN Alpha Fund and Speciale Invest, to boost clinical readiness and expand its pipeline.

#AIDrugDiscovery #BiotechFunding #Peptris #DeccanFounders #IANAlphaFund

age1 leads Series C as Loyal advances LOY-002 toward FDA approval, completing key requirements for conditional approval.

vist.ly/4r96v

#longevity #CanineHealth #VeterinaryMedicine #BiotechFunding #HealthyAging #FDAApproval #PetLongevity #DrugDevelopment

Altimmune raises $75 million to advance pemvidutide, a promising therapy tackling serious liver and metabolic diseases.

longevity.technology/news/altimmu...

#longevity #liverhealth #biotechfunding #phase3 #metabolichealth #clinicaltrials

Trinity Capital’s Rob Lake looks at private capital’s ability to stretch runway to achieve milestones while minimizing dilution
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation

Trinity Capital’s Rob Lake looks at private capital’s ability to stretch runway to achieve milestones while minimizing dilution
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation

Trinity Capital’s Rob Lake looks at some of the ways his platform recycles capital as investments achieve milestones or are acquired.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics

Trinity Capital’s Rob Lake offers a solution to young companies that may not realize the benefits of private capital.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma

Trinity Capital’s Rob Lake shares thoughts on some technologies that have potential in the life sciences.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation

Trinity Capital’s Rob Lake describes some of the financing options for biotech companies.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation

We speak with Trinity Capital’s Life Sciences Lead Rob Lake. He explains the components of return for private capital.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics
trinitycapital.com/life-sciences/

Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.

#BiotechFunding
#Startups
#LifeSciences

Want updates like this every week?
Follow me. Turn on notifications.

#BiotechFunding
#EuropeanStartups
#LifeSciencesNews

Current market challenges are redefining the biotech landscape - PMLiVE Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong

#biotech #biotechlandscape #investmentactivity #initialpublicoffering #MandA #biotechfunding #biotechfundinglandscape #NIH #FDA #FDAapproval #healthcareecosystem #biotechecosystem #biotechmarket #pharmacompanies #biotechcompanies #biotechsector #biotechIPOs
pmlive.com/intelligence...

Want more weekly insights like this?
Follow me and turn on notifications.
I post every Saturday.

#LifeSciences #BiotechFunding #EuropeBio

I track European life science fundings every week, so you don't have to.

🔔 Follow for your Saturday briefing
♻️ Repost to keep your network informed
#LifeSciences #BiotechFunding #HealthTech

Want more fundraising updates like this every Saturday?

🔔 Follow and turn on notifications

♻️ Repost to help others stay informed

#LifeScience #BiotechFunding #HealthTechEurope

AI biotech firm SpotitEarly raises $20.3M to scale noninvasive cancer detection in US Israeli artificial intelligence biotech startup SpotitEarly Ltd. today officially launched in the U.S. and announced that it has raised $20.3 million in new funding to scale up its U.S. presence and to...

AI biotech firm SpotitEarly raises $20.3M to scale noninvasive cancer detection in US #Technology #Business #HealthTech #SpotitEarly #CancerDetection #BiotechFunding

Excited to share that Christian, CEO of Solaxa, will speak at the COG DMV Area conference in Bethesda, MD, on May 13–14, 2025. He'll join a panel discussing funding strategies for clinical-stage biotechs.​

#COGDMV2025 #BiotechFunding #ClinicalTrials #Solaxa

Fundraising 🇺🇸 Isomorphic Labs Secures $600 Million to Advance AI-Driven Drug Discovery Isomorphic Labs, based in London, has raised $600 million to enhance its AI-driven drug discovery platform, leveraging tools like AlphaFold for efficient therapy development.

Isomorphic Labs: AI-driven drug discovery 🔬

Secures $600M funding to advance innovative drug design

London-based company revolutionizes pharma with AI platform

#IsomorphicLabs #AIDrugDiscovery #AlphaFold #BiotechFunding

Valo Therapeutics announces EUR 19m of investment funding and expanded clinical trials HELSINKI and NAPLES, Italy and PERTH, Australia, March 10, 2025 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy announces that it has successfully secured a...

🚨 Valo Therapeutics secured €19M funding to advance its PeptiCRAd cancer immunotherapy platform.

Clinical trials are planned in Italy, Australia, and Germany.

#CancerImmunotherapy #BiotechFunding #ClinicalTrials

3/7 "Why leave nature to chance?" asks Colossal CEO Ben Lamm, whose company has raised hundreds of millions from investors ranging from celebrities to the CIA.

The team altered mouse genes affecting hair texture and how the animals store and burn fat.
#BiotechFunding #GeneEditing

Antheia Lands $12M with Second BioMaP Deal to Reshape U.S. Pharma - SynBioBeta

The company was awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach a commercial scale in the U.S.

#PharmaInnovation #BiotechFunding #Biotechnology
@antheiabio

@BiomapI

Syndax Pharmaceuticals and Royalty Pharma Announce $350 Million Royalty Funding Agreement for Niktimvo™ Syndax Pharmaceuticals has entered into a substantial $350 million royalty funding agreement with Royalty Pharma, focused on the U.S.

www.linkedin.com/pulse/syndax...

Syndax Pharmaceuticals and Royalty Pharma Announce $350 Million Royalty Funding Agreement for Niktimvo™

#SyndaxPharma #RoyaltyPharma #Niktimvo #GVHD #BiotechFunding #Incyte #Biotechnology #Humanteconomy #Humantech

Biotech Limited Partners: learnings from investing in biotech venture capital funds Limited Partners (LPs) are at the heart of the biotech funding ecosystem—these crucial players ignite the funding flywheel that drives biotech innovation.

The #biotechfunding ecosystem is complex, with multiple players working together to advance #breakthroughmedicines. At the heart of this system are Limited Partners (LPs)—the crucial players who ignite the funding flywheel that drives #biotech #innovation.
vibebio.com/blog/biotech...